Prevention of Breast Cancer in Postmenopausal Women: Approaches to Estimating and Reducing Risk

被引:185
|
作者
Cummings, Steven R. [1 ,4 ]
Tice, Jeffrey A. [3 ]
Bauer, Scott [4 ,5 ]
Browner, Warren S. [1 ]
Cuzick, Jack [6 ]
Ziv, Elad [3 ]
Vogel, Victor [7 ]
Shepherd, John [2 ]
Vachon, Celine [8 ]
Smith-Bindman, Rebecca [2 ]
Kerlikowske, Karla [3 ,4 ]
机构
[1] Calif Pacific Med Ctr Res Inst, San Francisco Coordinating Ctr, San Francisco, CA 94107 USA
[2] Univ Calif San Francisco, Dept Radiol, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA
[4] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA
[5] Univ Calif Los Angeles, Los Angeles, CA USA
[6] Canc Res UK, London, England
[7] Univ Pittsburgh, Magee Womens Canc Ctr, Pittsburgh, PA USA
[8] Mayo Clin, Coll Med, Rochester, MN USA
来源
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2009年 / 101卷 / 06期
关键词
SURGICAL ADJUVANT BREAST; SERVICES-TASK-FORCE; CARCINOMA IN-SITU; RECREATIONAL PHYSICAL-ACTIVITY; HORMONE-RECEPTOR STATUS; ADULT WEIGHT CHANGE; BOWEL PROJECT P-1; MAMMOGRAPHIC DENSITY; ALCOHOL-CONSUMPTION; OVARIAN-CANCER;
D O I
10.1093/jnci/djp018
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background It is uncertain whether evidence supports routinely estimating a postmenopausal woman's risk of breast cancer and intervening to reduce risk. Methods We systematically reviewed prospective studies about models and sex hormone levels to assess breast cancer risk and used meta-analysis with random effects models to summarize the predictive accuracy of breast density. We also reviewed prospective studies of the effects of exercise, weight management, healthy diet, moderate alcohol consumption, and fruit and vegetable intake on breast cancer risk, and used random effects models for a meta-analyses of tamoxifen and raloxifene for primary prevention of breast cancer. All studies reviewed were published before June 2008, and all statistical tests were two-sided. Results Risk models that are based on demographic characteristics and medical history had modest discriminatory accuracy for estimating breast cancer risk (c-statistics range = 0.58-0.63). Breast density was strongly associated with breast cancer (relative risk [RR] = 4.03, 95% confidence interval [CI] = 3.10 to 5.26, for Breast Imaging Reporting and Data System category IV vs category I; RR = 4.20, 95% CI = 3.61 to 4.89, for >75% vs <5% of dense area), and adding breast density to models improved discriminatory accuracy (c-statistics range = 0.63-0.66). Estradiol was also associated with breast cancer (RR range = 2.0-2.9, comparing the highest vs lowest quintile of estradiol, P<.01). Most studies found that exercise, weight reduction, low-fat diet, and reduced alcohol intake were associated with a decreased risk of breast cancer. Tamoxifen and raloxifene reduced the risk of estrogen receptor-positive invasive breast cancer and invasive breast cancer overall. Conclusions Evidence from this study supports screening for breast cancer risk in all postmenopausal women by use of risk factors and breast density and considering chemoprevention for those found to be at high risk. Several lifestyle changes with the potential to prevent breast cancer should be recommended regardless of risk.
引用
收藏
页码:384 / 398
页数:15
相关论文
共 50 条
  • [1] Breast cancer prevention using anastrozole in postmenopausal women at high risk
    Cuzick, J.
    Sestak, I.
    Forbes, J. F.
    Dowsett, M.
    Knox, J.
    Cawthorn, S.
    Saunders, C.
    Roche, N.
    Mansel, R. E.
    von Minckwitz, G.
    Bonanni, B.
    Palva, T.
    Howell, A.
    CANCER RESEARCH, 2013, 73
  • [2] Update on raloxifene: role in reducing the risk of invasive breast cancer in postmenopausal women
    Vogel, Victor G.
    BREAST CANCER-TARGETS AND THERAPY, 2011, 3 : 127 - 137
  • [3] Primary prevention of breast cancer in postmenopausal women
    Cummings, Steven R.
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2007, 14 (06): : 1078 - 1078
  • [4] Reducing the risk for breast cancer recurrence after completion of tamoxifen treatment in postmenopausal women
    Jahanzeb, Mohammad
    CLINICAL THERAPEUTICS, 2007, 29 (08) : 1535 - 1547
  • [5] Randomized clinical trials of raloxifene: reducing the risk of osteoporosis and breast cancer in postmenopausal women
    Olevsky, Olga M.
    Martino, Silvana
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2008, 15 (04): : 790 - 796
  • [6] Exemestane for Breast-Cancer Prevention in Postmenopausal Women
    Goss, Paul E.
    Ingle, James N.
    Ales-Martinez, Jose E.
    Cheung, Angela M.
    Chlebowski, Rowan T.
    Wactawski-Wende, Jean
    McTiernan, Anne
    Robbins, John
    Johnson, Karen C.
    Martin, Lisa W.
    Winquist, Eric
    Sarto, Gloria E.
    Garber, Judy E.
    Fabian, Carol J.
    Pujol, Pascal
    Maunsell, Elizabeth
    Farmer, Patricia
    Gelmon, Karen A.
    Tu, Dongsheng
    Richardson, Harriet
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (25): : 2381 - 2391
  • [7] Exemestane for primary prevention of breast cancer in postmenopausal women
    Zhang, Yang
    Simondsen, Katherine
    Kolesar, Jill M.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2012, 69 (16) : 1384 - 1388
  • [8] Raloxifene (Evista) for breast cancer prevention in postmenopausal women
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2006, 48 (1234): : 37 - 37
  • [9] Breast cancer risk in overweight postmenopausal women
    Lahmann, PH
    Lissner, L
    Berglund, G
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2004, 13 (08) : 1414 - 1414
  • [10] Defining the risk threshold for risk reducing salpingo-oophorectomy for ovarian cancer prevention in low risk postmenopausal women
    Manchanda, Ranjit
    Legood, Rosa
    Pearce, Leigh
    Menon, Usha
    GYNECOLOGIC ONCOLOGY, 2015, 139 (03) : 487 - 494